The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boechat, N.
Right arrow Articles by Hance, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boechat, N.
Right arrow Articles by Hance, A. J.
The Journal of Immunology, 2001, 166: 6203-6211.
Copyright © 2001 by The American Association of Immunologists

Culture at High Density Improves the Ability of Human Macrophages to Control Mycobacterial Growth1

Neio Boechat*, Francine Bouchonnet*, Marcel Bonay*, Alain Grodet*, Vladimir Pelicic{dagger}, Brigitte Gicquel{dagger} and Allan J. Hance2,*

* Institut National de la Santé et de la Recherche Médicale, Unité 82, Institut National de la Santé et de la Recherche Médicale, Hôpital Bichat-Claude Bernard, Paris, France; and {dagger} Unité de Génétique Mycobactérienne, Institut Pasteur, Paris, France


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The mechanisms through which granuloma formation helps control mycobacterial infection are poorly understood, but it is possible that the accumulation of macrophages at high density at sites of infection promotes the differentiation of macrophages into cells with improved mycobactericidal activity. To test this possibility, varying numbers of monocytes were cultured in 96-well plates for 3 days, infected with Mycobacterium bovis bacillus Calmette-Guérin, and mycobacterial number was assessed 7 days after infection based on the measurement of luciferase activity expressed by a mycobacterial reporter strain or by counting CFU. Mycobacterial growth was optimal in cultures containing 5 x 104 cells/well, but increasing the number of cells to 2 x 105 cells/well resulted in complete inhibition of mycobacterial growth. This effect could not be explained by differences in mycobacterial uptake, multiplicity of infection, acidification of the extracellular medium in high density cultures, enhanced NO production, or paracrine stimulation resulting from secretion of cytokines or other proteins. The morphology of cells cultured at high density was strikingly different from that of monocytes cultured at 5 x 104 cells/well, including the appearance of numerous giant cells. The bacteriostatic activity of monocyte-derived macrophages was also dependent on cell number, but fewer of these more mature cells were required to control mycobacterial growth. Thus, the ability of human macrophages to control mycobacterial infection in vitro is influenced by the density of cells present, findings that may help explain why the formation of granulomas in vivo appears to be a key event in the control of mycobacterial infections.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Pathogenic mycobacteria survive and proliferate within mononuclear phagocytes, cells capable of eliminating most internalized organisms. The ability of the host response to increase the mycobactericidal activity of macrophages is clearly important in the development of an effective response. Numerous in vivo studies have shown that lymphocytes play an essential role in increasing the mycobactericidal activity of macrophages. For example, the depletion of CD4 T cells in humans infected with HIV-1 and the depletion of either CD4 or CD8 T cells in murine models leads to a severe impairment in the control of mycobacterial growth (1, 2, 3, 4). A number of cytokines are produced by T cells in the course of responses to mycobacterial infection, and several of these mediators have been shown to be essential for the development of mycobactericidal activity in vivo. Thus, inactivation of genes coding for IFN-{gamma} or its receptor, TNF-{alpha} or TNF receptors, IL-12, and IL-18 have all been shown to seriously impair host immunity in murine models (5, 6, 7, 8, 9, 10, 11), and the identification of mutations in the genes coding for IFN-{gamma} and IL-12 receptors in individuals with increased sensitivity to mycobacterial infection have confirmed the absolute requirement for these cytokines in the control of mycobacterial infection in humans (12, 13, 14, 15).

The mechanisms through which T cells increase the mycobactericidal activity of macrophages remain controversial. Studies evaluating murine macrophages in vitro have shown that cytokines produced by T cells, in particular the combination of TNF-{alpha} and IFN-{gamma}, can directly stimulate macrophage bactericidal activity, at least in part through the induction of NO synthetase activity (16, 17, 18). Numerous attempts to demonstrate similar effects of these cytokines on human macrophages have failed. Whether used individually or in combination, TNF-{alpha}, IFN-{gamma}, and IL-12 have not been found to reproducibly improve the mycobactericidal activity of human macrophages (19, 20, 21, 22). Taken together, these findings suggest that exposure to T cell-derived cytokines alone is not sufficient for the development of potent mycobactericidal activity in human macrophages. Several recent studies have suggested that cell-cell interactions between T cells and macrophages may also contribute to the development of mycobactericidal activity (22, 23, 24).

In addition, lymphocytes may act indirectly, by fostering the formation of well-developed immune granulomas, which are a constant feature of effective antimycobacterial responses in both experimental models and humans. Granulomas are composed of a central core of monocyte-derived cells expressing characteristic morphologic features (epithelioid macrophages and giant cells) that is surrounded by and infiltrated with activated CD4+ and CD8+ T cells. Cytokine secretion by T cells is required for granuloma formation in vivo, because depletion of T cells or inactivation of signaling by IFN-{gamma}, TNF-{alpha}, and IL-12 have all been shown to impair and/or delay granuloma formation (3, 4, 5, 6, 7, 8, 9, 10, 25, 26), and the extent of these abnormalities correlates with the overall impairment in mycobactericidal activity observed.

The mechanisms through which granuloma formation helps control mycobacterial infection are poorly understood, but it is possible that the accumulation of macrophages at high density at sites of infection promotes the differentiation of macrophages into cells with improved mycobactericidal activity. To test this possibility, we have evaluated the effect of macrophage density and maturation on the intracellular growth of Mycobacterium bovis bacillus Calmette-Guérin (BCG),3 and demonstrate that culture at high density considerably improves the ability of human macrophages to control mycobacterial proliferation. The evaluation of the mechanisms involved suggests that differences in their differentiated state, not the production of autocrine/paracrine mediators, are chiefly responsible for the improved bacteriostatic activity of these cells.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Purification and culture of human monocytes

PBMC were isolated from leukapheresis concentrates obtained from healthy volunteers by centrifugation on Lymphoprep (Nycomed Pharma, Oslo, Norway). Monocytes were then purified by counterflow centrifugal elutriation (27), using a J2-21 ME centrifuge and a JE-6B rotor (Beckman Instruments, Palo Alto, CA). Monocytes had a viability of >95% and a purity of at least 92% in all experiments. For some experiments, monocytes that had been frozen at -80°C in 10% DMSO were used.

To initiate experiments, monocytes were resuspended in complete medium (IMDM (Sigma, St. Louis, MO) supplemented with 2 mM L-glutamine (Life Technologies, Gaithersburg, MD), 200 U/ml penicillin G, 1 µg/ml kanamycin (Sigma), and 20% human AB serum (Institut Jacques Boy, Reims, France)). Cells were cultured in 96-well flat-bottom plates with opaque sides and transparent bottoms (EG&G Wallac, Turku, Finland) at concentrations ranging from 1 x 104 to 2 x 105 cells/well in a final volume of 200 µl medium. In most experiments, cells were maintained at 37°C in 95% air, 5% CO2 for 3 days before infection. In some experiments, cells were cultured for 10 days before infection, in which case medium was replaced after 7 days of culture.

Infection of monocytes

The construction of the mycobacterial reporter strain used in these studies has previously been described (19). Briefly, to obtain this strain, M. bovis BCG 1173 P2 (Pasteur Institute, Paris, France) was transformed with the plasmid pPV12, which contains the mycobacterial origin of replication from pAL5000, a kanamycin resistance gene, and the luciferase gene Luc1 from Photinus pyralis under control of the mycobacterial promoter Pan. Mycobacteria were grown at 37°C with gentle shaking in 7H9 liquid medium supplemented with Middlebrook ADC enrichment mixture (Difco, Detroit, MI) and 20 µg/ml kanamycin to an OD600 of {approx}1, resuspended by pipeting, diluted with an equal volume of 40% glycerol, and stored as 1.2-ml aliquots at -80°C. On the day of infection, stocks were thawed, 1.2 ml complete medium without serum were added, and aggregates were dispersed by three cycles of sonication (50 W, 30 s, 0°C) using a Vibracell sonicator (Sonics and Materials, Danbury, CT) followed by vortexing (5 s). Mycobacteria were pelleted by centrifugation (1800 x g for 10 min), resuspended in 3 ml complete medium without serum, and centrifuged (40 x g for 5 min) to pellet residual aggregates. The top 2.5 ml of the suspension were removed, and mycobacteria were quantified using a disposable counting chamber (Kova Slide 10; Hycor Biomedical, Irvine, CA). In most experiments, mycobacteria were diluted to 2 x 103 mycobacteria/µl. In experiments evaluating the effect of changes in the multiplicity of infection, suspensions containing a 4-fold higher and 4-fold lower concentration of organisms were also used. Most mycobacteria in the suspension were individual organisms, although a small proportion of aggregates containing fewer than five mycobacteria were also present. Essentially 100% of the organisms were viable as assessed using live/dead BacLight viability stain (Molecular Probes, Eugene, OR).

To infect cells, culture medium was removed, and 25 µl of the mycobacterial suspension were added (e.g., 5 x 104 mycobacteria/well), followed by fresh complete medium with or without other additions as indicated below to a final volume of 200 µl. At different times after infection, 175 µl medium were removed from each well, and the plates were either frozen at -20°C (for measurement of luciferase activity) or used immediately for the evaluation of CFU. In some experiments, wells were washed three times with 200 µl warmed complete medium before evaluating luciferase activity.

Evaluation of mycobacterial growth

Determination of luciferase activity. Mycobacterial number was assessed by measuring luciferase activity produced by the mycobacterial reporter strain as previously described (19). Briefly, 96-well plates where thawed, and 75 µl lysis reagent (Promega, Madison, WI) were added to lyse the macrophages and permeabilize the mycobacteria. Luminescence was then measured during a 50-s interval using a EG&G Berthold MicroLumat LB-96P luminometer, 1.6 s after automatic injection of 100 µl of the substrate solution containing luciferin and ATP (Luciferase Assay Reagent; Promega). In all experiments, results for each experimental condition, expressed as relative light units (RLU (3)/well, are the means of triplicate determinations.

CFU. After removal of 175 µl medium from each well, 50 µl 7H9 Middlebrook medium containing 0.1% SDS and 20 µg/ml kanamycin (37°C) were added. After a 30-min incubation at 37°C, 75 µl PBS containing 20% BSA was added, and the contents of each well were resuspended by vigorous pipeting. Three serial 10-fold dilutions were prepared using 7H9 Middlebrook medium, and 75-µl aliquots were plated in triplicate on petri dishes containing 7H10 medium supplemented with Middlebrook OADC enrichment mixture (Difco) and 20 µg/ml kanamycin. Plates were incubated at 37°C for 3 wk before colonies were counted. Results are expressed as CFU/well, and in all experiments are the average of triplicate values for each experimental condition.

When mycobacterial number was evaluated in parallel 24 h after infection based on CFU and RLU, a CFU:RLU ratio of 9.2 ± 3.7 (n = 8) was observed; this ratio was not different for cultures containing 5 x 104 and 2 x 105 cells/well. As indicated above, cultures were infected with ~5 x 104 mycobacteria/well. As expected, luciferase activity 24 h after infection was ~5000 RLU/well in all experiments, and the activity was similar in cultures containing 5 x 104 and 2 x 105 cells/well.

Evaluation of morphology and cell number

Cytologic evaluation was performed on cells grown under conditions identical with those used to evaluate mycobacterial growth. To evaluate cell morphology and viability, culture medium was removed and replaced with solution containing 50 ng/ml propidium iodide and 3 µg/ml acridine orange in PBS, and cultures were examined under epifluorescent illumination using an inverted Zeiss fluorescent microscope. To identify mycobacteria, culture medium was removed, and cells were fixed with 10% formalin for 30 min, washed with 100 µl PBS, and stained for 20 min with 30 µl 5 µg/ml acridine orange and 0.7 µg/ml propidium iodide in PBS. After washing with PBS, the bottom of each well was removed using a hollow steel punch, and the disc was attached to a microscope slide using Super Glue-3. Slides were immersed in methanol, dried, restained with 25 µl of the fluorescent dye solution, and rinsed successively with PBS and methanol. The slides were examined under epifluorescent illumination using a Leitz DMRD microscope camera system (Leica, Wetzlar, Germany). DNA content of cultures was determined using the method of Labarca and Paigen (28).

Modification of culture medium

In some experiments, the pH of culture medium (initially pH 7.7) was titrated with 1 M HCl to pH values between 6.4 and 7.5 after complete equilibration with 5% CO2. To produce macrophage-conditioned medium, purified human macrophages were cultured in 96-well plates at 2 x 105 cells/well in 200 µl complete medium. After 7 days, the medium was removed, centrifuged at 600 x g for 10 min to remove residual cells, titrated to pH 7.5 by the addition of 1 N NaOH, filtered through a 0.22-µm pore size membrane (Millex; Millipore, Bedford, MA), and stored at -20°C. Medium conditioned by Jurkat cells (TIB-152; American Type Culture Collection (ATCC)) and A549 lung carcinoma cells (CCL-185; ATCC) was produced by similar techniques. Cell number was adjusted such that the pH of the conditioned medium after 7 days of culture was similar to that of macrophage-conditioned medium (pH 6.5–6.6). In some experiments, conditioned medium was evaluated after dialysis (Slide-A-Lyser; Pierce, Rockford, IL) against complete medium without serum, after passage through filtration membranes with 3 or 100 kDa cutoffs (Centriprep concentrator; Amicon, Beverly, MA), in which case both the filtrate and the 10-fold concentrated retentate were tested, or after passage through a 1-ml C18 hydrophobic chromatographic cartridge (Waters, Milford, MA). To evaluate the effect of N-iminomethylornithine hydrochloride (L-NIL; Cayman Chemical, Ann Arbor, MI) on myocobacterial growth, a stock solution containing 4 µg/µl was prepared, and aliquots were added to the cultures to produce a final concentration of 5–125 µg/ml. Solutions were prepared contemporaneously from anhydrous solid at the time of addition.

Statistical methods

All results are expressed as mean ± SD unless otherwise indicated. Comparisons between groups were made by ANOVA. Posttest comparisons (performed only if p < 0.05) were made using the Newman-Keuls test.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Effect of macrophage numbers on mycobacterial growth

Monocytes were cultured for 3 days in 96-well plates, infected with a suspension of M. bovis BCG, and mycobacterial number was assessed 7 days after infection based on the measurement of luciferase activity expressed by the mycobacterial reporter strain. Mycobacterial growth was highly dependent on the number of human monocytes present in the cultures (Fig. 1GoA). In the absence of monocytes, little mycobacterial growth was observed. In cultures containing <5 x 103 macrophages/well, the viability of the heavily infected cells was poor. Thus, most mycobacteria were extracellular, because either they were deposited in the spaces between cells or released from dying cells, and no significant growth was seen. Mycobacterial growth was first observed in cultures containing 1 x 104 monocytes, and increased progressively as monocyte number was increased. Maximal mycobacterial growth was always observed in cultures containing either 2 x 104 (n = 3) or 5 x 104 cells/well (n = 5) in the eight experiments in which these two concentrations were compared. In cultures containing more monocytes, however, mycobacterial growth was partially (1 x 105 cells/well) or almost totally suppressed (2 x 105 cells/well) in all experiments.



View larger version (17K):
[in this window]
[in a new window]
 
FIGURE 1. Effect of cell number on the growth of M. bovis BCG in cultured human macrophages. A, Monocytes were purified by elutriation, cultured at the indicated number per well for 3 days, and infected with M. bovis BCG. Seven days after infection, culture medium was removed and the luciferase activity (RLU) expressed by the mycobacterial reporter strain was measured by luminometry. Dashed line, RLU/well for cultures containing BCG only evaluated 1 day after infection. Results, expressed as RLU, are the mean ± SD for triplicate determinations from a one of two experiments that gave similar results. B, Cultures containing 5 x 104 cells/well (•), 2 x 105 cells/well ({blacksquare}), prepared as described above, or no monocytes ({circ}) were infected with M. bovis BCG reporter strain, and luciferase activity was measured after the indicated time in culture. Results are the mean ± SD for nine independent experiments performed using cells obtained from different individuals.

 
To further explore this phenomenon, the kinetics of mycobacterial growth was evaluated in cultures containing numbers of macrophages that were optimal (5 x 104 cells/well) or inhibitory (2 x 105 cells/well) for growth (Fig. 1GoB). In cultures containing 5 x 104 cells/well, progressive mycobacterial growth was observed, resulting in a 15- ± 5-fold increase in RLU between 1 and 7 days. For cultures containing 2 x 105 cells/well, modest mycobacterial growth was observed at day 4 (2.5- ± 0.7-fold increase in RLU). Between days 4 and 7, however, luciferase activity decreased in six of nine experiments, resulting in an overall 1.4- ± 0.4-fold increase in RLU between 1 and 7 days. When mycobacteria were cultured in the absence of macrophages, no net growth was seen at 7 days.

To confirm the important effect of macrophage density on mycobacterial growth, a second technique was used to evaluate mycobacterial number. When mycobacterial growth in cultures containing 5 x 104 and 2 x 105 cells/well was assessed by the measurement of CFU, the results were comparable to those obtained using the luciferase assay (Fig. 2Go). When mycobacteria were cultured in the absence of macrophages, the number of CFU decreased progressively in all four experiments (data not shown).



View larger version (18K):
[in this window]
[in a new window]
 
FIGURE 2. Comparison of mycobacterial growth as assessed by measurement of luciferase activity and enumeration of CFU. Cultures containing 5 x 104 macrophages/well (•, {blacksquare}) or 2 x 105 macrophages/well ({circ}, {square}), prepared as described above, were infected with the M. bovis BCG reporter strain. After the indicated time in culture, the number of mycobacteria present were assessed by measuring luciferase activity (RLU, {square}, {blacksquare}) and colony forming units (CFU, {circ}, •). Results are presented as the mean ± SEM for four independent experiments performed using monocytes from different individuals.

 
Differences in mycobacterial uptake or the multiplicity of infection (MOI) do not explain the reduced mycobacterial growth in high density cultures

When cultures were infected for 24 h and washed three times before measuring luciferase activity, RLU in washed cultures represented 76 ± 13% (5 x 104 cells/well) and 74 ± 11% (2 x 105 cells/well) of the activity detected in unwashed cultures (n = 6, difference not significant). Furthermore, after washing, total RLU at day 1 were similar for cultures containing 5 x 104 and 2 x 105 cells/well. Thus, as previously described (20), most mycobacteria were cell associated in these cultures, and the subsequent differences in mycobacterial growth could not be explained by reduced uptake of mycobacteria in cultures containing 2 x 105 cells/well.

In experiments described thus far, cultures were infected with the same quantity of mycobacteria, irrespective of cell number. Therefore, it was important to demonstrate that the 4-fold increase in the number of mycobacteria/cell (MOI) found when comparing cultures containing 5 x 104 and 2 x 105 cells/well did not explain the differences in mycobacterial growth observed. We found, however, that despite varying the MOI over a 16-fold range, cultures containing 5 x 104 cells/well were permissive for mycobacterial growth, whereas cultures containing 2 x 105 cells/well were able to control mycobacterial growth (Fig. 3Go). Thus, when the number of mycobacteria used to infect cultures containing 2 x 105 cells/well was increased 4-fold compared with that used to infect cultures containing 5 x 104 cells/well, resulting in the same MOI for these cultures, high density cultures, but not low density cultures, could still control mycobacterial growth (compare solid bars in Fig. 3Go). Similarly, when the number of mycobacteria used to infect cells containing 5 x 104 cells/well was decreased 4-fold compared with that used to infect cultures containing 2 x 105 cells/well, low density cultures were still permissive for mycobacterial growth (compare hatched bars in Fig. 3Go), again indicating that the effect of cell number on mycobacterial growth is independent of MOI.



View larger version (27K):
[in this window]
[in a new window]
 
FIGURE 3. Effect of MOI on the growth of mycobacteria in macrophages cultivated at high and low density. Macrophages were cultivated at 5 x 104 cells/well (left) or 2 x 105 cells/well (right) for 3 days. For each experiment, serial 2-fold dilutions of the original suspension of the M. bovis BCG were prepared, and cells were infected with the indicated relative number of mycobacteria. The number of mycobacteria indicated as "1" corresponds to the amount generally used in these studies (i.e., 3–5 x 103 RLU/well corresponding to an MOI of ~1:1 in cultures containing 5 x 104 cells/well). Each group of three bars shows mycobacterial number assessed by measurement of RLU after 1 day (left bar), 4 days (middle bar), and 7 days (right bar). Results are presented as the mean ± SD for three experiments (mycobacterial numbers 1, 2, and 4) or one experiment (mycobacterial number 1/4). Cultures in which macrophages cultivated at 5 x 104 and 2 x 105 cells/well were infected at the same MOI are indicated by results shown with solid and hatched bars.

 
Effect of extracellular pH on mycobacterial growth in cultured macrophages

Macrophages cultured at 2 x 105 cells/well progressively acidified the culture medium, an effect that occurred to a much lesser extent when cells were cultured at 5 x 104 cells/well (Fig. 4GoA). To evaluate whether such acidification of the extracellular medium could contribute to the ability of macrophages to control mycobacterial proliferation, cultures containing 5 x 104 cells/well were infected for 24 h, after which the culture medium was replaced with medium previously adjusted to pH values between 6.8 and 7.7. For cells cultured initially at pH 6.8, the pH after 7 days was as low as that observed in cultures containing 2 x 105 cells/well (Fig. 4GoB). Nevertheless, acidification of the extracellular medium had little impact on the growth of mycobacteria at 4 or 7 days in macrophages cultured at 5 x 104 cells/well, whereas mycobacterial growth was controlled in cultures containing 2 x 105 cells/well. Thus, changes in the pH of the extracellular medium could not account for the differences in mycobacterial growth in low and high density cultures.



View larger version (21K):
[in this window]
[in a new window]
 
FIGURE 4. Effect of extracellular pH on the growth of mycobacteria in cultured macrophages. A, Macrophages were cultivated at 5 x 104 cells/well ({square}) or 2 x 105 cells/well ({blacksquare}) for 3 days, infected with M. bovis BCG, and pH of the extracellular medium was measured at the indicated times after infection. Results are the mean ± SD for five independent experiments. B, Macrophages were cultivated at 5 x 104 cells/well ({square}) or 2 x 105 cells/well ({blacksquare}) for 3 days and infected with the M. bovis BCG reporter strain, and 1 day after infection medium was replaced with culture medium adjusted to the indicated initial pH. Mycobacterial growth was assessed at the indicated times by evaluation of luciferase activity. The final pH of the culture medium is indicated by the values inside the bars. Results are the mean ± SD for three experiments performed using cells from different individuals.

 
Morphology and viability of cultured macrophages

When monocytes were plated at 5 x 104 cells/well, the cells rapidly formed a monolayer in which most cells were firmly attached to the surface. After infection, most cells remained adherent, although a small number of cell clusters were observed. The cells progressively increased in size, producing an essentially confluent monolayer at 7 days (Fig. 5GoA). At this time, essentially 100% of the cells were viable as assessed by their ability to exclude propidium iodide. After fixation and staining, small clusters of mycobacteria could be observed in most cells 7 days after infection (Fig. 5GoB). Although not quantified, the number of mycobacteria per cell clearly increased during the week after infection.



View larger version (74K):
[in this window]
[in a new window]
 
FIGURE 5. Morphologic features of infected cells. Human monocytes were plated at 5 x 104 cells/well (A and B) or 2 x 105 cells/well (C and D) for 3 days, infected with M. bovis BCG, and evaluated 7 days after infection. To evaluate cell morphology and viability (A and C), cells were stained in situ with propidium iodide and acridine orange, and photomicrographs were taken using an inverted fluorescence microscope. Under these conditions, viable cells fluoresce green with acridine orange and dead cells (C, arrowheads) fluoresce orange with propidium iodide. Note the presence of giant cells in high density cultures. To identify mycobacteria (B and D), cells were fixed with formalin and methanol and stained with propidium iodide and acridine orange, and photomicrographs were taken under oil immersion using a fluorescence microscope. Under these conditions, fixed macrophages fluoresce orange with propidium iodide, whereas mycobacteria fluoresce green with acridine orange. Magnifications in A/C and B/D are the same; bars represent 20 and 8 µm, respectively.

 
Several differences were observed when monocytes were plated at 2 x 105 cells/well. First, clusters of cells were prominent immediately after plating and increased in size after infection. Cell fusion, resulting in giant cell formation, was evident 4 days after infection; by 7 days after infection, large numbers of giant cells containing 5–15 nuclei were present (Fig. 5GoC). Despite the low pH of the extracellular medium, >90% of cells in high density cultures remained viable after 7 days of culture, although small numbers of dead cells were always present (orange nuclei in Fig. 5GoC). Subsequently, the viability of high density cultures declined, and at 10 days numerous dead cells were present. Cells with condensed nuclei typical of apoptotic cells were observed but were never abundant; very few nonadherent cells were observed in these cultures. To evaluate the possibility that dead cells were being lost from the cultures through ingestion and degradation by the remaining viable macrophages, the DNA content of adherent cells was measured after various times in culture. No significant change in DNA content was observed over the 7-day period in cultures containing 2 x 105 cells/well (day 0, 1.5 ± 0.5; day 7, 1.3 ± 0.6 µg DNA/well; n = 4; p > 0.05 by paired t test).

After fixation, mycobacteria were observed in high density cultures. In particular, individual mycobacteria or small aggregates were observed in the perinuclear region of some, but not all, giant cells (Fig. 5GoD, arrows). Isolated macrophages containing aggregates of mycobacteria, as observed in cultures plated at 5 x 104 cells/well, were infrequent. Overall, the number of mycobacteria per high power field was clearly reduced in high density cultures. The visualization of mycobacteria required fixation of the cells, and the viability of the intracellular mycobacteria could not be assessed.

Effect of macrophage-conditioned medium on mycobacterial growth

The impaired mycobacterial growth in high density cultures could result from either the production of factors by macrophages that improve their mycobactericidal activity or the depletion of metabolites necessary for mycobacterial growth. To test these possibilities, macrophages were cultured at 2 x 105 cells/well for 7 days, and the conditioned medium was removed, neutralized to pH 7.5, and added to cultures containing 5 x 104 macrophages/well 1 day after infection. As shown in Fig. 6GoA, mycobacterial growth at 7 days was significantly reduced in cells maintained in the presence of macrophage-conditioned medium at dilutions of 1/2 and 1/4 (p < 0.01 and p < 0.05, respectively) compared with that observed in cells cultured in unconditioned medium. The inhibitory activities of conditioned medium from infected and uninfected macrophages were similar (data not shown). Although mycobacterial growth was reduced in cells cultured with macrophage-conditioned medium for 7 days, significant proliferation did occur and was always greater than that observed in cultures containing macrophages at high density (percent inhibition of RLU relative to cultures containing 5 x 104 macrophages: 5 x 104 macrophages receiving conditioned medium on day 1, 68 ± 9%; 2 x 105 macrophages, 93 ± 2%; n = 5, p < 0.01). The effect observed with conditioned medium was not increased by addition on two occasions (percent inhibition of RLU: 5 x 104 macrophages receiving conditioned medium on days 1 and 4, 62 ± 26%; 2 x 105 macrophages, 93 ± 3%; n = 2). Conditioned medium did not influence the growth of mycobacteria cultured in the absence of monocytes at 4 or 7 days (p > 0.4 for both comparisons, n = 3).



View larger version (30K):
[in this window]
[in a new window]
 
FIGURE 6. Effect of conditioned medium on mycobacterial growth in human macrophages. A, One day after infection, medium was removed and replaced with fresh medium (-) or the indicated dilution of macrophage-conditioned medium (e.g., medium recovered from macrophages maintained at 2 x 105 cells/well for 7 days and neutralized to pH 7.5). B, Macrophages were cultivated at 5 x 104 cells/well ({square}, , , ) or 2 x 105 cells/well ({blacksquare}) for 3 days and infected with the M. bovis BCG reporter strain. One day after infection, medium was removed and replaced with fresh medium (-) or a 1/2 dilution of medium conditioned by macrophages (M), Jurkat cells (J), or A549 carcinoma cells (A). Mycobacterial growth was assessed at the indicated times by evaluation of luciferase activity. Results are the mean ± SD for four experiments performed using cells from different individuals.

 
Filtration of conditioned medium using filters with 100- or 3-kDa cutoffs did not decrease the inhibitory activity, although the activity was lost after dialysis (Table IGo). Heating of conditioned medium or passage through a C18 hydrophobic chromatography column did not reduce the inhibitory activity. The use of fresh medium that had been titrated to pH 6.5 using dilute HCl and then neutralized to pH 7.4 did not reduce mycobacterial growth.


View this table:
[in this window]
[in a new window]
 
Table I. Effect of pretreatment of macrophage-conditioned medium on its ability to inhibit mycobacterial growth in human macrophages1

 
When 5 x 104 macrophages were cultured in the presence of conditioned medium, their morphologic features were generally similar to those of cells maintained in standard medium. At 7 days, cell contours were somewhat less uniform and appeared to result from partial detachment of some cells from the surface. The prominent cluster formation and cell fusion seen in high density cultures was not observed.

To evaluate whether the suppressive effect on mycobacterial growth was a unique property of macrophage-conditioned medium, medium conditioned by other cell types was also evaluated. Jurkat cells and A549 carcinoma cells were grown in complete medium until the pH was equivalent to that of macrophage-conditioned medium, the medium was removed and neutralized to pH 7.5, and the effects of these conditioned media were compared (Fig. 6GoB). Although macrophage-conditioned medium was somewhat more inhibitory, medium conditioned by the other cell types also decreased mycobacterial growth at 7 days, and the differences in inhibition comparing the three media were not significantly different (n = 4, p > 0.05). As above, high density macrophages had a significantly greater inhibitory effect on mycobacterial growth than low density macrophages cultured with conditioned medium.

Effect of L-NIL on mycobacterial growth in macrophages cultured at high density

To evaluate whether NO production was required for the improved mycobacteriostatic activity of macrophages cultured at high density, the effect of the L-NIL, an inducible NO synthase inhibitor, was evaluated. The addition of 5 µg/ml L-NIL on the day of infection did not increase mycobacterial growth at 7 days (RLU/well at 7 days: control, 3870 ± 1326; L-NIL, 4140 ± 1878 RLU/well; p > 0.2). Increasing the concentration of L-NIL to 125 µg/ml or adding 5 µg/ml L-NIL every 48 h after infection also failed to increase mycobacterial growth (data not shown).

Effect of macrophage maturity on the control of mycobacterial growth

In the experiments described thus far, monocytes were infected after 3 days of culture in vitro. To determine whether the maturation of these cells influenced the relationship between cell number and their ability to control mycobacterial growth, monocytes from the same individuals cultured for 3 and 10 days before infection were compared. As described above, monocytes plated at 2 x 104 and 5 x 104 cells/well, but not cells plated at 2 x 105 cells/well, were permissive for mycobacterial growth (Fig. 7GoA). Monocytes cultured for 10 days before infection exhibited progressive differentiation into large macrophage-like cells that were firmly adherent to the culture wells. Interestingly, when cultured at 2 x 104 cells/well, these macrophage-like cells were still permissive for mycobacterial growth, but cultures containing 5 x 104 differentiated macrophages controlled mycobacterial growth as well as cultures containing 2 x 105 monocytes infected 3 days after isolation (p > 0.2 at 4 and 7 days comparing the two populations shown in Fig. 7Go, A and B).



View larger version (15K):
[in this window]
[in a new window]
 
FIGURE 7. Effect of maturation on the ability of macrophages to control mycobacterial replication. Monocytes from a given donor were purified by elutriation and frozen in aliquots. Either 3 days before infection (A) or 10 days before infection (B), aliquots were thawed and cultured at 2 x 104 ({circ}), 5 x 104 (•), or 2 x 105 ({blacksquare}) cells/well. At the indicated times after infection, mycobacterial growth was assessed by evaluation of luciferase activity. Because of the high metabolic activity of differentiated macrophages, cultures containing 2 x 105 cells/well had poor viability after 10 days of culture, and mycobacterial growth could not be evaluated. Results are the mean ± SD for four experiments performed using cells from three individuals.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
This study demonstrates that the ability of human monocyte-derived macrophages to control mycobacterial infection in vitro is highly dependent on the density at which these cells are present. When plated at a density that results in a single monolayer of cells after 7 days of culture, we found that monocytes were permissive for growth of M. bovis BCG, findings consistent with previous reports (29, 30). When the same cells were plated at a 2- to 4-fold higher density, however, mycobacterial growth was strongly inhibited, and, in some experiments net mycobactericidal activity was observed. These findings demonstrate that human monocytes have the intrinsic capacity to develop in vitro into cells capable of controlling mycobacterial infection.

The role of a number of possible mechanisms through which changes in cell density could influence mycobactericidal activity were investigated. Cell density did not change mycobacterial uptake by the cultured macrophages. Furthermore, the effect of macrophage density on mycobacterial growth was insensitive to the multiplicity of infection over a 16-fold range. Thus, neither of these factors could explain the observed effect.

The control of intraphagosomal pH is also thought to be an important determinant of mycobacterial survival in macrophages. Mycobacterial growth can be directly influenced by an acidic environment, and acidification can increase their sensitivity to oxidant-mediated killing (31, 32). Virulent mycobacteria have been reported to inhibit the acidification of phagosomes through exclusion of vesicular proton-ATPase complexes (33). Acidification of the extracellular milieu can also decrease the intracellular pH of macrophages (34), and we found that macrophages cultured at high density did acidify the extracellular medium to a pH as low as 6.5 after 7 days. Several observations suggested, however, that this change did not account for improved mycobacteriostasis. First, despite acidification of the culture medium to similar levels, macrophages cultured at lower density remained permissive for mycobactericidal growth. In addition, the viability of high density macrophages remained excellent despite the low extracellular pH, suggesting that these cells maintained a physiologic intracellular pH via energy-dependent transport mechanisms. Similarly, the bactericiostatic activity of macrophages cultured at high density could not be attributed to the preferential generation of NO by these cells, because treatment with the inducible NO synthase inhibitor L-NIL did not influence their ability to control mycobacterial replication. Consistent with these observations, prior studies have shown that although human macrophages express inducible NO synthase after mycobacterial infection (35, 36), the levels of NO produced are low, and the inhibition of NO production by human macrophages does not reproducibly increase mycobacterial growth (36, 37). Increased apoptosis of macrophages infected with mycobacteria has been described and in some but not all cases has been associated with mycobacterial killing (38, 39, 40, 41). In this study, the viability of macrophages cultured at high density was excellent at 7 days, few detached cells were present, and the DNA content of the cultures was stable during the 7-day culture period. These findings indicate that macrophage apoptosis or ingestion of infected apoptotic cells by neighboring uninfected macrophages is unlikely to account for the reduced mycobacterial growth seen in high density cultures.

Two observations in our study suggested that the differentiated state of macrophages have an important bearing on their ability to control mycobacterial infection and that both the time in culture and the density of cells present could influence this differentiation process. The mycobacteriostatic activity of both freshly isolated monocytes and macrophages that had been cultured for 10 days before infection was dependent on the number of cells present in the cultures, but fewer of the more differentiated macrophage-like cells were required to control mycobacterial proliferation. Prior studies have shown that the maturation in vitro of human monocytes before infection can modify their capacity to control mycobacterial replication. In these studies, however, an increase (42), a progressive decrease (43), or an initial decrease followed by an increase (44) in the permissiveness for mycobacterial infection has been observed as a function of the time in culture. The important effect of cell density was not evaluated in these studies and may account, at least in part, for the discrepant findings. We also observed that the morphologic features of monocytes cultured at high density were strikingly different from those of cells cultured at low density. In high density cultures, macrophages were larger, cell aggregates were prominent during the first few days of culture, and later times the progressive appearance of giant cells was observed. These changes occurred to a similar extent in uninfected cultures, indicating that mycobacterial infection was not responsible. Byrd (45) previously observed an association between giant cell formation and the ability of cultured monocytes to inhibit mycobacterial proliferation. As in his study, we observed that mycobacteria accumulated in the perinuclear area of giant cells, which may restrict the invasion of adjacent cells (45). A number of signals have been described that increase giant cell formation in cultured macrophages (46, 47, 48). Conditioned medium from high density macrophage cultures did not induce giant cell formation in low density cultures, suggesting that paracrine stimulation by cytokines was not sufficient for the induction of giant cell formation seen in these studies. Culture of cells at high density resulted in the early formation of cell aggregates, compatible with the idea that prolonged membrane contact may have been important.

It should be emphasized that the relationship between increased mycobacteriostatic activity and macrophage differentiation observed in these studies does not prove that the processes are causally related. Furthermore, giant cell formation was not a feature of either low density cultures treated with conditioned medium or macrophages cultured at 5 x 104 cells/well for 10 days before infection, although these populations were able, respectively, to partially or completely inhibit mycobacterial replication. Thus, this type of differentiation, although possibly important, was not indispensable for improved mycobacteriostatic activity. Future studies evaluating the effect of inhibiting macrophage differentiation on mycobacteriostatic activity may prove informative. In this regard, we have recently found that when monocytes are cultured with type I IFNs, they persist as small "monocyte-like" cells for up to 7 days. Under these conditions, monocytes are very permissive to mycobacterial growth, even when cultured at high density (F. Bouchonnet, N. Boechat, M. Bonay, M. Vokurka, and A. J. Hance, manuscript in preparation).

An interesting finding in the current studies was the observation that when low density macrophages were maintained in the presence of medium conditioned by high density macrophages, intracellular mycobacterial growth was reduced. This finding is compatible with the possibility that high density cultures release factor(s) that can stimulate mycobacteriostatic activity or deplete metabolites necessary for mycobacterial growth. The observation that medium conditioned by other cell types also decreased mycobacterial growth in low density macrophages suggests that this effect is not specific for macrophages. Furthermore, modification of the extracellular milieu did not appear to completely explain the increased mycobacteriostatic activity of cells cultured at high density, because low density macrophages cultured in conditioned medium inhibited mycobacterial growth less well than macrophages cultured at high density, and cells cultured in conditioned medium, unlike high density cultures, did not inhibit mycobacterial growth at 4 days.

The ability of conditioned medium to enhance mycobacteriostatic activity was not decreased by heating, passage through a membrane with a 3-kDa cutoff or passage through a C18 hydrophobic column, whereas the activity was completely lost by dialysis. In addition, the 10-fold concentrated retentate obtained by ultrafiltration of conditioned medium did not contain increased activity. These findings argue strongly against a role for soluble secreted proteins or lipid mediators in this phenomenon. Thus, although cultured macrophages are secrete large quantities of cytokines, including IFN-{gamma}, TNF-{alpha}, and IL-12 (22, 23, 30, 49, 50), our results are compatible with prior studies indicating that these cytokines are not sufficient to induce strong mycobactericidal activity in otherwise permissive human macrophages. Low molecular mass substances produced by macrophages, and other cell types can modify the activity of macrophages and improve their resistance to intracellular pathogens, (e.g., ATP and nonheme iron) (20, 51), and the release of such agents could explain our findings. Attempts to isolate a putative stimulatory factor by ion exchange chromatography were unsuccessful, but the buffers required for these studies proved to be toxic for macrophages, which complicated this endeavor (data not shown). Alternatively, it is the possibility that substances that deactivate macrophages or that are required for optimal mycobacterial growth had been depleted by the metabolically active cells (e.g., iron, adenosine, amino acids) (52, 53, 54, 55, 56). The activity of conditioned medium was completely lost after dialysis against serum-free medium, indicating that the culture medium, not human serum, would have to be the source of such a metabolite. Furthermore, because conditioned medium diluted 4-fold with fresh medium retained some activity, this metabolite would have to be present in suboptimal amounts in fresh medium. Further studies will be required to identify the substances responsible for the effects observed with conditioned medium and to determine whether macrophages within granulomas can "condition" their environment in a similar fashion.

Taken together, these results indicate that the ability of human macrophages to control mycobacterial infection in vitro is strongly influenced by the density of cells present and indicate that cell density and the time in culture before infection can influence the differentiated state of these cells and their capacity to modify the external milieu. The requirement for both monocytes and more mature macrophages to be present at a critical density to suppress mycobacterial proliferation offer insights into why the formation of granulomas in vivo appears to be a key event in the control of mycobacterial infections. The availability of this model, in which the same cells are either permissive or resistant to mycobacterial infection, should be useful in further characterizing the cellular events that are indispensable for the development of mycobactericidal activity.


    Acknowledgments
 
We thank Dr. Sitthy (Hôpital St. Louis, Paris, France) for help in obtaining normal human leukocytes.


    Footnotes
 
1 This work was supported in part by a grant from Sidaction/Fondation pour la Recherche Médicale. N.B. was supported by a fellowship from the Brazilian Council of Research. Back

2 Address correspondence and reprint requests to Dr. Allan J. Hance, Institut National de la Santé et de la Recherche Médicale Unité 552, IMEA-Institut National de la Santé et de la Recherche Médicale, Hôpital Bichat-Claude Bernard, 46 rue Henri Huchard, 75018 Paris, France. Back

3 Abbreviations used in this paper: BCG, bacillus Calmette-Guérin; L-NIL, N-iminomethylornithine hydrochloride; MOI, multiplicity of infection; RLU, relative light units. Back

Received for publication October 16, 2000. Accepted for publication March 8, 2001.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Havlir, D. V., P. F. Barnes. 1999. Tuberculosis in patients with human immunodeficiency virus infection. N. Engl. J. Med. 340:367.[Free Full Text]
  2. Flynn, J. L., M. M. Goldstein, K. J. Triebold, B. Koller, B. R. Bloom. 1992. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. USA 89:12013.[Abstract/Free Full Text]
  3. Ladel, C. H., S. Daugelat, S. H. E. Kaufmann. 1995. Immune response to Mycobacterium bovis bacille Calmette Guérin infection in major histocompatibility complex class I- and II-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance. Eur. J. Immunol. 25:377.[Medline]
  4. Caruso, A. M., N. Serbina, E. Klein, K. Triebold, B. R. Bloom, J. L. Flynn. 1999. Mice deficient in CD4 T-cells have only transiently diminished levels of IFN-{gamma}, yet succumb to tuberculosis. J. Immunol. 162:5407.[Abstract/Free Full Text]
  5. Flynn, J. L., J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, B. R. Bloom. 1993. An essential role for interferon {gamma} in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2249.[Abstract/Free Full Text]
  6. Cooper, A. M., D. K. Dalton, T. A. Stewart, J. P. Griffin, D. G. Russell, I. M. Orme. 1993. Disseminated tuberculosis in interferon {gamma} gene-disrupted mice. J. Exp. Med. 178:2243.[Abstract/Free Full Text]
  7. Kamijo, R., J. Le, D. Shapiro, E. A. Havell, S. Huang, M. Aguet, M. Bosland, J. Vilcek. 1993. Mice that lack the interferon-{gamma} receptor have profoundly altered responses to infection with bacillus Calmette-Guérin and subsequent challenge with lipopolysaccharide. J. Exp. Med. 178:1435.[Abstract/Free Full Text]
  8. Flynn, J. L., M. M. Goldstein, J. Chan, K. J. Triebold, K. Pfeffer, C. J. Lowenstein, R. Schreiber, T. W. Mak, B. R. Bloom. 1995. Tumor necrosis factor-{alpha} is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2:561.[Medline]
  9. Bean, A. G. D., D. R. Roach, H. Briscoe, M. P. France, H. Korner, J. D. Sedgwick, W. J. Britton. 1999. Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. J. Immunol. 162:3504.[Abstract/Free Full Text]
  10. Cooper, A. M., J. Magram, J. Ferrante, I. M. Orme. 1997. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J. Exp. Med. 186:39.[Abstract/Free Full Text]
  11. Sugawara, I., H. Yamada, H. Kaneko, S. Mizuno, K. Takeda, S. Akira. 1999. Role of interleukin-18 (IL-18) in mycobacterial infection in IL-18-gene-disrupted mice. Infect. Immun. 67:2585.[Abstract/Free Full Text]
  12. Newport, M. J., C. M. Huxley, S. Huston, C. M. Hawrylowicz, B. A. Oostra, R. Williamson, M. Levin. 1996. A mutation in the interferon-{gamma}-receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 335:1941.[Abstract/Free Full Text]
  13. Jouanguy, E., F. Altare, S. Lamhamedi, P. Revy, J. F. Emile, M. Newport, M. Levin, S. Blanche, E. Seboun, A. Fischer, J.-L. Casanova. 1996. Interferon-{gamma}-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. N. Engl. J. Med. 335:1956.[Free Full Text]
  14. Altare, F., A. Durandy, D. Lammas, J.-F. Emile, S. Lamhamedi, F. Le Deist, P. Drysdale, E. Jouanguy, R. Döffinger, F. Bernaudin, et al 1998. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 280:1432.[Abstract/Free Full Text]
  15. de Jong, R. F., I.-A. Altare, D. G. Haagen, T. Elferink, P. J. C. de Boer, P. J. van BredaVriesman, J. M. T. Kabel, J. T. Draaisma, F. P. Kroon van Dissel, et al 1998. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 280:1435.[Abstract/Free Full Text]
  16. Flesch, I. E., S. H. E. Kaufmann. 1990. Activation of tuberculostatic macrophage functions by {gamma} interferon, interleukin-4, and tumor necrosis factor. Infect. Immun. 58:2675.[Abstract/Free Full Text]
  17. Chan, J., K. Tanaka, D. Carroll, J. Flynn, B. R. Bloom. 1993. Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Infect. Immun. 63:736.[Abstract]
  18. MacMicking, J., R. J. North, R. Lacourse, R. S. Mudgett, S. Shah, C. F. Nathan. 1997. Identification of NOS2 as a protective locus against tuberculosis. Proc. Natl. Acad. Sci. USA 94:5243.[Abstract/Free Full Text]
  19. Bonay, M., F. Bouchonnet, V. Pelicic, B. Lagier, M. Grandsaigne, D. Lecossier, A. Grodet, M. Vokurka, B. Gicquel, A. J. Hance. 1999. Effect of stimulation of human macrophages on intracellular survival of Mycobacterium bovis bacillus Calmette-Guerin: evaluation with a mycobacterial reporter strain. Am. J. Respir. Crit. Care Med. 159:1629.[Abstract/Free Full Text]
  20. Byrd, T. F.. 1997. Tumor necrosis factor {alpha} (TNF{alpha}) promotes growth of virulent Mycobacterium tuberculosis in human monocytes. Iron-mediated growth suppression is correlated with decreased release of TNF{alpha} from iron-treated infected monocytes. J. Clin. Invest. 99:2518.[Medline]
  21. Warwick-Davies, J., J. Dhillon, L. O’Brien, P. W. Andrew, D. B. Lowrie. 1994. Apparent killing of Mycobacterium tuberculosis by cytokine-activated human monocytes can be an artifact of a cytotoxic effect on the monocytes. Clin. Exp. Immunol. 96:214.[Medline]
  22. Silver, R. F., Q. Li, W. H. Boom, J. J. Ellner. 1998. Lymphocyte-dependent inhibition of growth of virulent Mycobacterium tuberculosis H37Rv within human monocytes: requirement for CD4+ T cells in purified protein derivative-positive, but not in purified protein derivative-negative subjects. J. Immunol. 160:2408.[Abstract/Free Full Text]
  23. Bonecini-Almeida, M., S. Chitale, I. Boutsikakis, J. Geng, H. Doo, Suhui He, J. L. Ho. 1998. Induction of in vitro human macrophage anti-Mycobacterium tuberculosis activity: requirement for IFN-{gamma} and primed lymphocytes. J. Immunol. 160:4490.[Abstract/Free Full Text]
  24. Yoneda, T., J. J. Ellner. 1998. CD4+ T cell and natural killer cell-dependent killing of Mycobacterium tuberculosis by human monocytes. Am. J. Respir. Crit. Care Med. 158:395.[Abstract/Free Full Text]
  25. Kindler, V., A.-P. Sapppino, G. E. Grau, P.-F. Piguet, and P. Vassalli. 1989. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56:7.31.
  26. Wakeham, J., J. Wang, J. Magram, K. Croitoru, R. Harkness, P. Dunn, A. Zganiacz, Z. Xing. 1998. Lack of both types 1 and 2 cytokines, tissue inflammatory responses, and immune protection during pulmonary infection by Mycobacterium bovis bacille Calmette-Guérin in IL-12-deficient mice. J. Immunol. 160:6101.[Abstract/Free Full Text]
  27. Wahl, L. M., I. L. Katona, R. L. Wilder, C. C. Winter, B. Haroui, I. Seher, S. M. Wahl. 1984. Isolation of human mononuclear cell subsets by counterflow centrifugal elutriation (CEE). I. Characterization of B-lymphocyte, T-lymphocyte and monocyte-enriched fractions by flow cytometric analysis. Cell. Immunol. 85:373.[Medline]
  28. Labarca, C., K. Paigen. 1980. A simple, rapid, and sensitive DNA assay procedure. Anal. Biochem. 102:344.[Medline]
  29. Molloy, A., P. A. Meyn, K. D. Smith, G. Kaplan. 1993. Recognition an destruction of bacillus Calmette-Guérin-infected human monocytes. J. Exp. Med. 177:1691.[Abstract/Free Full Text]
  30. Silver, R. F., Q. Li, J. J. Ellner. 1998. Expression of virulence of Mycobacterium tuberculosis within human monocytes: virulence correlates with intracellular growth and induction of tumor necrosis factor {alpha} but not with evasion of lymphocyte-dependent monocyte effector functions. Infect. Immun. 66:1190.[Abstract/Free Full Text]
  31. Jackett, P. S., V. R. Aber, D. B. Lowrie. 1978. Virulence and resistance to superoxide, low pH and hydrogen peroxide among strains of Mycobacterium tuberculosis. J. Gen. Microbiol. 104:37.[Abstract/Free Full Text]
  32. Piddington, D. L., A. Kashkouli, N. A. Buchmeier. 2000. Growth of Mycobacterium tuberculosis in a defined medium is very restricted by acid pH and Mg2+ levels. Infect. Immun. 68:4518.[Abstract/Free Full Text]
  33. Sturgill-Koszycki, S., P. H. Schlesinger, P. Chakrabgorty, P. L. Haddix, H. L. Collins, A. K. Fok, R. D. Allen, S. L. Gluck, J. Heuser, D. G. Russell. 1994. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science 263:678.[Abstract/Free Full Text]
  34. Mellergard, P., Y. Ou-Yang, B. K. Siesjo. 1994. Relationship between intra- and extracellular pH in primary cultures of rat astrocytes. Am. J. Physiol. 267:C581.[Abstract/Free Full Text]
  35. Nicolson, S., M. Bonecini- Aleida, J. R. Lapa e Silva, C. Nathan, Q. Xie, R. Mumford, J. R. Weidner, J. Calaycay, J. Geng, N. Boechat, et al 1996. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J. Exp. Med. 183:2293.[Abstract/Free Full Text]
  36. Jagannath, C., J. K. Actor, Jr R. L. Hunter. 1998. Induction of nitric oxide in human monocytes and monocyte cell lines by Mycobacterium tuberculosis. Nitric Oxide 2:174.[Medline]
  37. Aston, C., W. N. Rom, A. T. Talbot, J. Reibman. 1998. Early inhibition of mycobacterial growth by human alveolar macrophages is not due to nitric oxide. Am. J. Respir Crit. Care Med. 157:1943.[Abstract/Free Full Text]
  38. Molloy, A., P. Laochumroonvorapong, G. Kaplan. 1994. Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guérin. J. Exp. Med. 180:1499.[Abstract/Free Full Text]
  39. Laochumroonvorapong, P., S. Paul, K. B. Elkon, G. Kaplan. 1996. H2O2 induces monocyte apoptosis and reduces viability of Mycobacterium avium-M. intracellulare within cultured human monocytes. Infect. Immun. 64:452.[Abstract]
  40. Fratazzi, C., R. D. Arbeit, C. Carini, H. G. Remold. 1997. Programmed cell death of Mycobacterium avium serovar 4-infected human macrophages prevents the mycobacteria from spreading and induces mycobacterial growth inhibition by freshly added, uninfected macrophages. J. Immunol. 158:4320.[Abstract]
  41. Keane, J., H. G. Remold, H. Kornfeld. 2000. Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages. J. Immunol. 164:2016.[Abstract/Free Full Text]
  42. Carvalho de Sousa, J. P., N. Rastogi. 1992. Comparative ability of human monocytes and macrophages to control the intracellular growth of Mycobacterium avium and Mycobacterium tuberculosis: effect of interferon-{gamma} and indomethacin. FEMS Microbiol. Immunol. 4:329.[Medline]
  43. Paul, S., P. Laochumroonvorapong, G. Kaplan. 1996. Comparable growth of virulent and avirulent Mycobacterium tuberculosis in human macrophages in vitro. J. Infect. Dis. 174:105.[Medline]
  44. Douvas, G. S., E. M. Berger, J. E. Repine, A. J. Crowle. 1986. Natural mycobacteriostatic activity in human monocyte-derived adherent cells. Am. Rev. Respir. Dis. 134:44.[Medline]
  45. Byrd, T. F.. 1998. Multinucleated giant cell formation induced by IFN-{gamma}/IL-3 is associated with restriction of virulent Mycobacterium tuberculosis cell to cell invasion in human monocyte monolayers. Cell. Immunol. 188:89.[Medline]
  46. Enelow, R. I., G. W. Sullivan, H. T. Carper, G. L. Mandell. 1992. Induction of multinucleated giant cell formation from in vitro culture of human monocytes with interleukin-3 and interferon-{gamma}: comparison with other stimulating factors. Am. J. Respir. Cell Mol. Biol. 6:57.
  47. Ohgimoto, S., N. Tabata, S. Suga, M. Nishio, H. Ohta, M. Tsurudome, H. Komada, M. Kawano, N. Watanabe, Y. Ito. 1995. Molecular characterization of fusion regulatory protein-1 (FRP-1) that induces multinucleated giant cell formation of monocytes and HIV gp160-mediated cell fusion. FRP-1 and 4F2/CD98 are identical molecules. J. Immunol. 155:3585.[Abstract]
  48. DeFife, K. M., C. R. Jenney, A. K. McNally, E. Colton, J. M. Anderson. 1997. Interkeukin-13 induces human monocyte/macrophage fusion and macrophage mannose receptor expression. J. Immunol. 158:3385.[Abstract]
  49. Zhang, M., J. Gong, Y. Lin, P. F. Barnes. 1998. Growth of virulent and avirulent Mycobacterium tuberculosis strains in human macrophages. Infect. Immun. 66:794.[Abstract/Free Full Text]
  50. Wallis, R. S., J. J. Ellner. 1994. Cytokines and tuberculosis. J. Leukocyte Biol. 55:676.[Abstract]
  51. Lammas, D. A., C. Stober, C. J. Harvey, N. Kendrick, S. Panchalingam, D. S. Kumararatne. 1997. ATP-induced killing of mycobacteria by human macrophages is mediated by purinergic P2Z(P2X7) receptors. Immunity 7:433.[Medline]
  52. Douvas, G. S., M. H. May, J. R. Pearson, E. Lam, L. Miller, N. Tsuchida. 1994. Hypertriglyceridemic serum, very low density lipoprotein, and iron enhance Mycobacterium avium replication in human macrophages. J. Infect. Dis. 170:1248.[Medline]
  53. Xaus, J., M. Mirabet, J. Lloberas, C. Soler, C. Lluis, R. Franco, A. Celada. 1999. IFN-{gamma} up-regulates the A2B adenosine receptor expression in macrophages: a mechanism of macrophage deactivation. J. Immunol. 162:3607.[Abstract/Free Full Text]
  54. Pfefferkorn, E.. 1984. Interferon-{gamma} blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cell to degrade tryptophan. Proc. Natl. Adad. Sci. USA 81:908.[Abstract/Free Full Text]
  55. Taylor, M. W., G. Feng. 1991. Relationship between interferon-{gamma}, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J. 5:2516.[Abstract]
  56. Harth, G., M. A. Horwitz. 1999. An inhibitor of exported Mycobacterium tuberculosis glutamine synthetase selectively blocks the growth of pathogenic mycobacteria in anexic culture and in human monocytes: extracellular proteins as potential novel durg targets. J. Exp. Med. 189:1425.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
F. A. W. Verreck, T. de Boer, D. M. L. Langenberg, M. A. Hoeve, M. Kramer, E. Vaisberg, R. Kastelein, A. Kolk, R. de Waal-Malefyt, and T. H. M. Ottenhoff
Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria
PNAS, March 30, 2004; 101(13): 4560 - 4565.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Tailleux, O. Neyrolles, S. Honore-Bouakline, E. Perret, F. Sanchez, J.-P. Abastado, P. H. Lagrange, J. C. Gluckman, M. Rosenzwajg, and J.-L. Herrmann
Constrained Intracellular Survival of Mycobacterium tuberculosis in Human Dendritic Cells
J. Immunol., February 15, 2003; 170(4): 1939 - 1948.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
F. Bouchonnet, N. Boechat, M. Bonay, and A. J. Hance
Alpha/Beta Interferon Impairs the Ability of Human Macrophages To Control Growth of Mycobacterium bovis BCG
Infect. Immun., June 1, 2002; 70(6): 3020 - 3025.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boechat, N.
Right arrow Articles by Hance, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boechat, N.
Right arrow Articles by Hance, A. J.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS